Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis.

MLA

Beddingfield, Brandon J., et al. “Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis.” The Journal of Infectious Diseases, vol. 226, no. 9, Nov. 2022, pp. 1588–92. EBSCOhost, https://doi.org/10.1093/infdis/jiac134.

APA

Beddingfield, B. J., Rowe, L. A., Russell-Lodrigue, K. E., Doyle-Meyers, L. A., Golden, N., Spencer, S., Chirichella, N., Blair, R. V., Maness, N. J., & Roy, C. J. (2022). Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis. The Journal of Infectious Diseases, 226(9), 1588–1592. https://doi.org/10.1093/infdis/jiac134

Chicago

Beddingfield, Brandon J, Lori A Rowe, Kasi E Russell-Lodrigue, Lara A Doyle-Meyers, Nadia Golden, Skye Spencer, Nicole Chirichella, Robert V Blair, Nicholas J Maness, and Chad J Roy. 2022. “Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis.” The Journal of Infectious Diseases 226 (9): 1588–92. doi:10.1093/infdis/jiac134.